Fertility Expansion Evvy is expanding from vaginal microbiome diagnostics into fertility diagnostics and related fertility support services following a $40M Series B led by Catalio Capital Management.

AI Driven The launch of an AI advisor for vaginal health leveraging a large dataset of microbiome tests positions Evvy to offer personalized recommendations and higher engagement, presenting upsell opportunities to ongoing tests and coaching.

Home Testing Scale Recent at‑home testing launches for vaginal health and UTI create recurrent consumer touchpoints and potential cross-sell between platforms, enabling a direct-to-consumer sales motion and data-rich onboarding.

Clinical Collaboration Evvy combines testing, precision clinical care, and 1:1 coaching, suggesting partnerships with clinics, OB/GYN networks, and fertility specialists to integrate Evvy’s platform into standard care pathways.

Funding & Growth Series B funding signals strong growth potential and validation; sales opportunities include expanding research collaborations, data partnerships, and enterprise adoption with healthcare providers and payers.